S Munkvad|J Jespersen|J Sidelmann|J Gram - JoVE Visualize

Showing results (1-10 of 337) with videos related to

Pageof 34

Sort By:

Clinical Chemistry|July 1, 1990

Specific, sensitive, precise, and rapid functional chromogenic assay of activated first complement component (C1) in plasmaS Munkvad, J Jespersen, J Sidelmann, et al.

European Heart Journal|June 1, 1990

A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarctionS Munkvad, J Gram, J Jespersen

Scandinavian Journal of Rheumatology|January 1, 1989

Depressed plasma fibrinolytic activity in a group of patients with connective tissue diseasesS Munkvad, J Gram, J Jespersen

Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1991

Possible role of vascular intima for generation of coagulant activity in patients undergoing coronary thrombolysis with recombinant tissue-type plasminogen activator. A randomized, placebo-controlled studyS Munkvad, J Gram, J Jespersen

American Journal of Obstetrics and Gynecology|July 1, 1990

Enhanced generation and resolution of fibrin in women above the age of 30 years using oral contraceptives low in estrogenJ Gram, S Munkvad, J Jespersen

Lymphokine and Cytokine Research|August 1, 1991

Interleukin-1 and tumor necrosis factor-alpha in plasma of patients with acute ischemic heart disease who undergo thrombolytic therapy: a randomized, placebo-controlled studyS Munkvad, J Gram, J Jespersen

Clinical Chemistry|July 1, 1995

Plasminogen activator activity and plasma-coagulum lysis measured by use of optimized fibrin gel structure preformed in microtiter platesJ Sidelmann, J Jespersen, J Gram

Thrombosis and Haemostasis|August 1, 1995

Does low protein concentration of tissue-type plasminogen activator predict a low risk of spontaneous deep vein thrombosis?J Gram, J Sidelmann, J Jespersen

Journal of Internal Medicine|October 1, 1990

Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endotheliumS Munkvad, J Jespersen, J Gram, et al.

Journal of the American College of Cardiology|August 1, 1991

Depression of factor XII-dependent fibrinolytic activity characterizes patients with early myocardial reinfarction after recombinant tissue-type plasminogen activator therapyS Munkvad, J Jespersen, J Gram, et al.

Pageof 34

Showing results (1-10 of 337) with videos related to

Sort By:

Pageof 34

Clinical Chemistry|July 1, 1990

Specific, sensitive, precise, and rapid functional chromogenic assay of activated first complement component (C1) in plasmaS Munkvad, J Jespersen, J Sidelmann, et al.

European Heart Journal|June 1, 1990

A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarctionS Munkvad, J Gram, J Jespersen

Scandinavian Journal of Rheumatology|January 1, 1989

Depressed plasma fibrinolytic activity in a group of patients with connective tissue diseasesS Munkvad, J Gram, J Jespersen

Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1991

Possible role of vascular intima for generation of coagulant activity in patients undergoing coronary thrombolysis with recombinant tissue-type plasminogen activator. A randomized, placebo-controlled studyS Munkvad, J Gram, J Jespersen

American Journal of Obstetrics and Gynecology|July 1, 1990

Enhanced generation and resolution of fibrin in women above the age of 30 years using oral contraceptives low in estrogenJ Gram, S Munkvad, J Jespersen

Lymphokine and Cytokine Research|August 1, 1991

Interleukin-1 and tumor necrosis factor-alpha in plasma of patients with acute ischemic heart disease who undergo thrombolytic therapy: a randomized, placebo-controlled studyS Munkvad, J Gram, J Jespersen

Clinical Chemistry|July 1, 1995

Plasminogen activator activity and plasma-coagulum lysis measured by use of optimized fibrin gel structure preformed in microtiter platesJ Sidelmann, J Jespersen, J Gram

Thrombosis and Haemostasis|August 1, 1995

Does low protein concentration of tissue-type plasminogen activator predict a low risk of spontaneous deep vein thrombosis?J Gram, J Sidelmann, J Jespersen

Journal of Internal Medicine|October 1, 1990

Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endotheliumS Munkvad, J Jespersen, J Gram, et al.

Journal of the American College of Cardiology|August 1, 1991

Depression of factor XII-dependent fibrinolytic activity characterizes patients with early myocardial reinfarction after recombinant tissue-type plasminogen activator therapyS Munkvad, J Jespersen, J Gram, et al.

Pageof 34